Suppr超能文献

片剂溶出受药物与崩解剂之间水分介导的固态相互作用影响。

Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant.

作者信息

Rohrs B R, Thamann T J, Gao P, Stelzer D J, Bergren M S, Chao R S

机构信息

Pharmaceutical Development, Pharmacia & Upjohn, Kalamazoo, Michigan 49001, USA.

出版信息

Pharm Res. 1999 Dec;16(12):1850-6. doi: 10.1023/a:1018951309506.

Abstract

PURPOSE

To investigate the cause for decrease in delavirdine mesylate 200 mg tablet dissolution upon exposure to high humidity.

METHODS

Dissolution testing was performed using the USP 2 (paddle) apparatus. Water in tablets was measured by Karl Fischer titration. 13C CP/MAS NMR was used to identify and quantify delavirdine form changes in tablets. FT-IR spectroscopy was used to monitor delavirdine form change in tablets and component mixes, and to investigate a solid state reaction with the disintegrant.

RESULTS

Dissolution extent of delavirdine mesylate 200 mg tablets was substantially decreased after exposure to high humidity. This effect is related to the amount of water present in the tablet matrix. 13C CP/ MAS NMR detected about 30% conversion from the mesylate salt of delavirdine to its free base form in the tablet matrix. FT-IR spectroscopy demonstrated that a solid state reaction occurs between the freed methanesulfonic acid and the carboxyl sites on the croscarmellose sodium disintegrant.

CONCLUSIONS

Water is thought to act as both a reaction medium and a plasticizer for croscarmellose sodium, facilitating protonation of the carboxyl sites on the disintegrant. This reaction has the potential to occur for any acid salt of a free base. The limiting solubility of delavirdine free base formed in the tablets accounts for much of the decrease in the extent of dissolution. A change in inter-particle bonding can explain the reduction in tablet deaggregation during dissolution.

摘要

目的

研究甲磺酸地拉韦定200mg片剂在高湿度条件下溶出度降低的原因。

方法

采用美国药典2(桨法)装置进行溶出度测试。通过卡尔费休滴定法测定片剂中的水分。采用13C CP/MAS NMR鉴定并定量片剂中甲磺酸地拉韦定的晶型变化。利用傅里叶变换红外光谱法监测片剂及组分混合物中甲磺酸地拉韦定的晶型变化,并研究其与崩解剂的固态反应。

结果

甲磺酸地拉韦定200mg片剂在高湿度条件下暴露后,溶出度显著降低。这种影响与片剂基质中存在的水量有关。13C CP/MAS NMR检测到片剂基质中甲磺酸地拉韦定的甲磺酸盐约有30%转化为其游离碱形式。傅里叶变换红外光谱法表明,游离的甲磺酸与交联羧甲基纤维素钠崩解剂上的羧基位点之间发生了固态反应。

结论

水被认为既是反应介质,又是交联羧甲基纤维素钠的增塑剂,促进了崩解剂上羧基位点的质子化。这种反应可能发生在任何游离碱的酸盐上。片剂中形成的甲磺酸地拉韦定游离碱的极限溶解度是溶出度降低的主要原因。颗粒间结合的变化可以解释溶出过程中片剂崩解的减少。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验